IN SILICO ANALYSIS OF BIOACTIVITY POTENTIAL AND PHARMACOKINETIC CHARACTERISTICS OF GRASS JELLY (Cyclea barbata) SECONDARY METABOLITES USING PASS ONLINE AND SWISSADME
ANALISIS IN SILICO POTENSI BIOAKTIVITAS DAN KARAKTERISTIK FARMAKOKINETIK METABOLIT SEKUNDER CINCAU HIJAU (Cyclea barbata) MENGGUNAKAN PASS ONLINE DAN SWISSADME
DOI:
https://doi.org/10.71275/roce.v3i2.205Keywords:
Cyclea barbata, green grass jelly, bioactivity, SwissADME, pkCSM, phytopharmaceuticalAbstract
Green grass jelly (Cyclea barbata Miers) is a medicinal plant that contains various secondary metabolites with potential as sources of phytopharmaceutical candidates. This study aimed to analyze the bioactivity potential, drug-likeness characteristics, pharmacokinetic profile, medicinal chemistry properties, and toxicity of secondary metabolites present in Cyclea barbata using an in silico approach. The identified compounds were analyzed using PASS Online for biological activity prediction, SwissADME for drug-likeness and pharmacokinetic evaluation, and pkCSM for ADME/T (Absorption, Distribution, Metabolism, Excretion, and Toxicity) prediction. The results showed that tyramine and dopamine exhibited the highest biological activity as serotonin-release stimulants and MAP kinase pathway activators. Coclaurine, norcoclaurine, and N-methylcoclaurine demonstrated favorable drug-likeness profiles by satisfying most of the Lipinski, Veber, and Egan criteria. Pharmacokinetic analysis indicated that most simple compounds possessed high gastrointestinal absorption, whereas complex alkaloids such as tetrandrine and fangchinoline exhibited broader tissue distribution potential and greater blood–brain barrier permeability. Medicinal chemistry evaluation revealed that all compounds were free from PAINS alerts, while toxicity prediction indicated relatively favorable safety profiles for most compounds. The findings suggest that Cyclea barbata has considerable potential as a source of bioactive compounds for the development of modern phytopharmaceuticals, particularly as neuroprotective and anti-inflammatory agents. However, further validation through in vitro and in vivo studies is required to confirm the efficacy and safety of the predicted compounds.
Downloads
References
Ancuceanu, R., Lascu, B. E., Drăgănescu, D., & Dinu, M. (2025). In Silico ADME Methods Used in the Evaluation of Natural Products. Pharmaceutics, 17(8). https://doi.org/10.3390/pharmaceutics17081002
Aryal, B., Raut, B. K., Bhattarai, S., Bhandari, S., Tandan, P., Gyawali, K., Sharma, K., Ranabhat, D., Thapa, R., Aryal, D., Ojha, A., Devkota, H. P., & Parajuli, N. (2022). Potential Therapeutic Applications of Plant-Derived Alkaloids against Inflammatory and Neurodegenerative Diseases. Evidence-Based Complementary and Alternative Medicine : ECAM, 2022, 7299778. https://doi.org/10.1155/2022/7299778
Asano, D., Takakusa, H., & Nakai, D. (2023). Oral Absorption of Middle-to-Large Molecules and Its Improvement, with a Focus on New Modality Drugs. Pharmaceutics, 16(1). https://doi.org/10.3390/pharmaceutics16010047
Batheja, S., Choudhary, S., Manuja, K., Goyal, R., Kumar, B., & Manuja, A. (2026). Docking simulations and multi-parameter ADMET profiling to decode quinapyramine sulfate’s strength and weakness. In Silico Research in Biomedicine, 2, 100145. https://doi.org/https://doi.org/10.1016/j.insi.2025.100145
Bhalani, D. V, Nutan, B., Kumar, A., & Singh Chandel, A. K. (2022). Bioavailability Enhancement Techniques for Poorly Aqueous Soluble Drugs and Therapeutics. Biomedicines, 10(9). https://doi.org/10.3390/biomedicines10092055
Bhandare, S. D. (2025). Advancements in toxicological risk assessment: integrating Ferguson’s principle, computational models, and drug safety guidelines, a comprehensive framework for improving risk assessment and resource management in toxicology. Toxicology Research, 14(3), tfaf065. https://doi.org/10.1093/toxres/tfaf065
Dahan, A., & Miller, J. M. (2012). The solubility-permeability interplay and its implications in formulation design and development for poorly soluble drugs. The AAPS Journal, 14(2), 244–251. https://doi.org/10.1208/s12248-012-9337-6
Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 42717. https://doi.org/10.1038/srep42717
Dizeyi, N., Hedlund, P., Bjartell, A., Tinzl, M., Austild-Taskén, K., & Abrahamsson, P.-A. (2011). Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines. Urologic Oncology, 29(4), 436–445. https://doi.org/10.1016/j.urolonc.2009.09.013
Dzobo, K. (2022). The Role of Natural Products as Sources of Therapeutic Agents for Innovative Drug Discovery. In Comprehensive Pharmacology (pp. 408–422). https://doi.org/10.1016/B978-0-12-820472-6.00041-4
Febrianto, S., Praharsini, F. V., Annas, Z. F., & Hanifa, N. I. (2022). Cyclea barbata L. Miers.: Penggunaan tradisional, fitokimia, dan aktivitas farmakologi. Sasambo Journal of Pharmacy, 3(2), 69–82. https://doi.org/10.29303/sjp.v3i2.178
Gessner, A., Picurová, J., Englhard, L., Müller, F., Fromm, M. F., & König, J. (2025). Putative new biomarkers for renal transporter-mediated drug-drug interactions: Characterization as substrates of organic cation transporter 2, multidrug and toxin extrusion protein 1, and other important drug transporters. Drug Metabolism and Disposition: The Biological Fate of Chemicals, 53(10), 100155. https://doi.org/10.1016/j.dmd.2025.100155
Guo, Y., Peng, X., Liu, F., Zhang, Q., Ding, L., Li, G., & Qiu, F. (2024). Potential of natural products in inflammation: biological activities, structure–activity relationships, and mechanistic targets. Archives of Pharmacal Research, 47. https://doi.org/10.1007/s12272-024-01496-z
Hanoum, S., & Shubbak, M. (2025). Enhancing Efficiency in Multi-Stage Pharmaceutical Manufacturing: A Process-Based Network DEA Approach. F1000Research, 14, 710. https://doi.org/10.12688/f1000research.166387.2
Heinrich, M., Mah, J., & Amirkia, V. (2021). Alkaloids Used as Medicines: Structural Phytochemistry Meets Biodiversity-An Update and Forward Look. Molecules (Basel, Switzerland), 26(7). https://doi.org/10.3390/molecules26071836
Huang, X., Choi, S., Wu, W., Shahi, P. K., Lee, J. H., Hong, C., & Jun, J. Y. (2024). 5-Hydroxytryptamine Enhances the Pacemaker Activity of Interstitial Cells of Cajal in Mouse Colon. International Journal of Molecular Sciences, 25(7). https://doi.org/10.3390/ijms25073997
Izatunnafis, I., Murti, Y., & Sudarmanto, B. (2023). In silico Pharmacokinetic and Toxicity Prediction of Compounds from Andrographis paniculata (Burm.f.) Nees. Journal of Food and Pharmaceutical Sciences, 830–838. https://doi.org/10.22146/jfps.7436
Jahangir, M., Gowtham, L., Nath, M., Halder, N., & Velpandian, T. (2026). Trace amine associated receptors in neuronal circuits: Mechanistic insights for therapeutic interventions. European Journal of Pharmacology, 1023, 178861. https://doi.org/https://doi.org/10.1016/j.ejphar.2026.178861
Jusko, N. M., Karekar, N., Cao, A., & Sun, D. (2026). AI and machine learning for predicting in vitro/preclinical drug toxicities and adverse events in clinical patients. Acta Pharmaceutica Sinica B. https://doi.org/https://doi.org/10.1016/j.apsb.2026.05.028
Li, C., Li, Z., & Zheng, Y. (2025). Natural products targeting the MAPK signaling pathway: potential options for ulcerative colitis treatment. Frontiers in Pharmacology, 16, 1721584. https://doi.org/10.3389/fphar.2025.1721584
Li, Y., Meng, Q., Yang, M., Liu, D., Hou, X., Tang, L., Wang, X., Lyu, Y., Chen, X., Liu, K., Yu, A.-M., Zuo, Z., & Bi, H. (2019). Current trends in drug metabolism and pharmacokinetics. Acta Pharmaceutica Sinica. B, 9(6), 1113–1144. https://doi.org/10.1016/j.apsb.2019.10.001
Lin, J.-F., Liu, Y.-S., Huang, Y.-C., Chi, C.-W., Tsai, C.-C., Tsai, T.-H., & Chen, Y.-J. (2022). Borneol and Tetrandrine Modulate the Blood-Brain Barrier and Blood-Tumor Barrier to Improve the Therapeutic Efficacy of 5-Fluorouracil in Brain Metastasis. Integrative Cancer Therapies, 21, 15347354221077682. https://doi.org/10.1177/15347354221077682
Liu, M., Svirskis, D., Proft, T., Loh, J., Yin, N., Li, H., Li, D., Zhou, Y., Chen, S., Song, L., Chen, G., Lu, W.-Y., Zhang, Z., Zhou, Z., Li, L., Huang, Y., Bunt, C., Sun, G., Harris, P. W. R., … Wen, J. (2025). Progress in peptide and protein therapeutics: Challenges and strategies. Acta Pharmaceutica Sinica. B, 15(12), 6342–6381. https://doi.org/10.1016/j.apsb.2025.10.026
Lombardo, F., Desai, P., Arimoto, R., Desino, K., Fischer, H., Keefer, C., Petersson, C., Winiwarter, S., & Broccatelli, F. (2017). In Silico Absorption, Distribution, Metabolism, Excretion, and Pharmacokinetics (ADME-PK): Utility and Best Practices. An Industry Perspective from the International Consortium for Innovation through Quality in Pharmaceutical Development. Journal of Medicinal Chemistry, 60. https://doi.org/10.1021/acs.jmedchem.7b00487
Maulana, A. F., Sriwidodo, S., Maksum, I. P., & Rukayadi, Y. (2026). In silico based exploration of natural and synthetic antidiabetic compounds: A comprehensive review of computational approaches. ADMET & DMPK, 14, 3070. https://doi.org/10.5599/admet.3070
Moldovan, C., Frumuzachi, O., Babotă, M., Barros, L., Mocan, A., Carradori, S., & Crişan, G. (2022). Therapeutic Uses and Pharmacological Properties of Shallot (Allium ascalonicum): A Systematic Review. Frontiers in Nutrition, 9, 903686. https://doi.org/10.3389/fnut.2022.903686
Ngcobo, N. N. (2025). Influence of Ageing on the Pharmacodynamics and Pharmacokinetics of Chronically Administered Medicines in Geriatric Patients: A Review. Clinical Pharmacokinetics, 64(3), 335–367. https://doi.org/10.1007/s40262-024-01466-0
Onoue, S., Yamada, K., & Sato, H. (2026). Advanced oral drug delivery systems: Current challenges and emerging technologies. Acta Pharmaceutica Sinica. B, 16(4), 2029–2042. https://doi.org/10.1016/j.apsb.2025.11.036
Otagiri, M. (2009). Study on Binding of Drug to Serum Protein. Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan, 129, 413–425. https://doi.org/10.1248/yakushi.129.413
Pooten, E. E., Cruz, K. G. J., Abella, E. A., Laserna, A. K. C., Islam, A. B. M. M. K., & Watanabe, K. (2025). Anticancer potential of Dendrocnide meyeniana through phytochemical profiling, ADMET analysis, molecular docking, and in silico cytotoxicity evaluation. Scientific Reports, 16(1), 2704. https://doi.org/10.1038/s41598-025-32457-1
Purwaningsih, I., Maksum, I. P., Sumiarsa, D., & Sriwidodo, S. (2025). Pharmacokinetics and Toxicity Overview of Active Compounds Berberine, Palmatine, and Jatrorrhizine From Fibraurea tinctoria Lour: Drug-Likeness, ADMET Prediction, and In Vivo Extract Toxicity Assessment. Journal of Toxicology, 2025, 7251602. https://doi.org/10.1155/jt/7251602
Queiroz Pantaleão, S., Fernandes, P., Gonçalves, J., Maltarollo, V., & Honório, K. (2021). Recent Advances in the Prediction of Pharmacokinetics Properties in Drug Design Studies: A Review. ChemMedChem, 17. https://doi.org/10.1002/cmdc.202100542
R, P., Rudrappa, M., Bhat, M. P., R, A., B, A. G., Hugar, M., & Nayaka, S. (2025). In-silico investigation on drug likeness, toxicity and molecular docking on lung cancer proteins of metabolites from Indigofera hochstetteri Baker methanol extract. In Silico Research in Biomedicine, 1, 100041. https://doi.org/https://doi.org/10.1016/j.insi.2025.100041
Rai, M., Singh, A. V., Paudel, N., Kanase, A., Falletta, E., Kerkar, P., Heyda, J., Barghash, R. F., Pratap Singh, S., & Soos, M. (2023). Herbal concoction Unveiled: A computational analysis of phytochemicals’ pharmacokinetic and toxicological profiles using novel approach methodologies (NAMs). Current Research in Toxicology, 5, 100118. https://doi.org/10.1016/j.crtox.2023.100118
Sauvant, M. P., Pepin, D., & Piccinni, E. (1999). Tetrahymena pyriformis: a tool for toxicological studies. A review. Chemosphere, 38(7), 1631–1669. https://doi.org/10.1016/s0045-6535(98)00381-6
Sjögren, E., Thörn, H., & Tannergren, C. (2016). In Silico Modeling of Gastrointestinal Drug Absorption: Predictive Performance of Three Physiologically Based Absorption Models. Molecular Pharmaceutics, 13(6), 1763–1778. https://doi.org/10.1021/acs.molpharmaceut.5b00861
Srivastava, A., Ahmad, A., Siddiqui, S., & Islam, A. (2026). Innovations in targeted drug delivery: From nanotechnology to clinical applications. Next Nanotechnology, 9, 100336. https://doi.org/https://doi.org/10.1016/j.nxnano.2025.100336
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002). Molecular properties that influence the oral bioavailability of drug candidates. Journal of Medicinal Chemistry, 45(12), 2615–2623. https://doi.org/10.1021/jm020017n
Verma, A. K., Ahmed, S., Hossain, M., Bhojiya, A., Mathur, A., Upendra, S., Srivastava, A., Vishvakarma, N., Barik, M., Bahadur, N., & Rahaman, M. M. (2021). Molecular docking and simulation studies of flavonoid compounds against PBP-2a of methicillin-resistant Staphylococcus aureus. Journal of Biomolecular Structure & Dynamics, 40, 10561–10577. https://doi.org/10.1080/07391102.2021.1944911
Wang, F., Dong, L., Hu, J., Yang, S., Wang, L., Zhang, Z., Zhang, W., & Zhuang, X. (2024). Quantitative pulmonary pharmacokinetics of tetrandrine for SARS-CoV-2 repurposing: a physiologically based pharmacokinetic modeling approach. Frontiers in Pharmacology, 15, 1457983. https://doi.org/10.3389/fphar.2024.1457983
Wink, M. (2015). Modes of Action of Herbal Medicines and Plant Secondary Metabolites. Medicines (Basel, Switzerland), 2(3), 251–286. https://doi.org/10.3390/medicines2030251
Wu, D., Chen, Q., Chen, X., Han, F., Chen, Z., & Wang, Y. (2023). The blood-brain barrier: structure, regulation, and drug delivery. Signal Transduction and Targeted Therapy, 8(1), 217. https://doi.org/10.1038/s41392-023-01481-w
Xu, T., Xu, Y., Zhang, J., Zhou, Y., Feng, H., Zhang, A., & Zhang, Y. (2026). Advances in AI for predicting pharmacological properties of natural medicines. Life Sciences, 387, 124180. https://doi.org/https://doi.org/10.1016/j.lfs.2025.124180
Zhao, D., Ma, L., Brownlie, J., Tonissen, K., Pan, Y., & Feng, Y. (2025). Neuroprotective Potential of Major Alkaloids from Nelumbo nucifera (Lotus): Mechanisms and Therapeutic Implications. International Journal of Molecular Sciences, 26(17). https://doi.org/10.3390/ijms26178280
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Dimas Tama Suryadinata, Oktaviola Dea, Wildan Yudistira, Rofi Sufyan Zaki, Ana Maria Susana, Abdurrohman Rosyid, Ebenezer, Dodi Iskandar (Author)
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
